<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Neurochem Res</journal-id>
      <journal-title>Neurochemical Research</journal-title>
      <issn pub-type="ppub">0364-3190</issn>
      <issn pub-type="epub">1573-6903</issn>
      <publisher>
        <publisher-name>Kluwer Academic Publishers-Plenum Publishers</publisher-name>
        <publisher-loc>New York</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">17094036</article-id>
      <article-id pub-id-type="pmc">1832150</article-id>
      <article-id pub-id-type="publisher-id">9190</article-id>
      <article-id pub-id-type="doi">10.1007/s11064-006-9190-z</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Paper</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Human Coenzyme Q<sub>10</sub> Deficiency</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Quinzii</surname>
            <given-names>Catarina M.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>DiMauro</surname>
            <given-names>Salvatore</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Hirano</surname>
            <given-names>Michio</given-names>
          </name>
          <address>
            <phone>+1-212-305-1048</phone>
            <fax>+1-212-305-3986</fax>
            <email>mh29@columbia.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1">Department of Neurology, Columbia University Medical Center, New York, NY 10032 USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>10</day>
        <month>11</month>
        <year>2006</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>4</month>
        <year>2007</year>
      </pub-date>
      <volume>32</volume>
      <issue>4-5</issue>
      <fpage>723</fpage>
      <lpage>727</lpage>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>7</month>
          <year>2006</year>
        </date>
        <date date-type="accepted">
          <day>3</day>
          <month>10</month>
          <year>2006</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Springer Science+Business Media, LLC 2006</copyright-statement>
      </permissions>
      <abstract>
        <p>Ubiquinone (coenzyme Q<sub>10</sub> or CoQ<sub>10</sub>) is a lipid-soluble component of virtually all cell membranes and has multiple metabolic functions. Deficiency of CoQ<sub>10</sub> (MIM 607426) has been associated with five different clinical presentations that suggest genetic heterogeneity, which may be related to the multiple steps in CoQ<sub>10</sub> biosynthesis. Patients with all forms of CoQ<sub>10</sub> deficiency have shown clinical improvements after initiating oral CoQ<sub>10</sub> supplementation. Thus, early diagnosis is of critical importance in the management of these patients. This year, the first molecular defect causing the infantile form of primary human CoQ<sub>10</sub> deficiency has been reported. The availability of genetic testing will allow for a better understanding of the pathogenesis of this disease and early initiation of therapy (even presymptomatically in siblings of patients) in this otherwise life-threatening infantile encephalomyopathy.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>CoQ10</kwd>
        <kwd>Mitochondria</kwd>
        <kwd>Encephalopathy</kwd>
        <kwd>Myopathy</kwd>
        <kwd>Cerebellar ataxia</kwd>
      </kwd-group>
      <custom-meta-wrap>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer Science+Business Media, LLC 2007</meta-value>
        </custom-meta>
      </custom-meta-wrap>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>Coenzyme Q<sub>10</sub> (CoQ<sub>10</sub>) is the predominant human form of endogenous ubiquinone. Synthesized in the mitochondrial inner membrane, CoQ<sub>10</sub> is comprised of a ubiquinone head group attached to a tail of 10 five-carbon isoprenoid units, that anchors the molecule to the membranes [<xref ref-type="bibr" rid="CR1">1</xref>]. In additions to its central role in the mitochondrial respiratory chain as electrons carrier from complex I and II to complex III [<xref ref-type="bibr" rid="CR2">2</xref>], CoQ<sub>10</sub> is now thought to be involved in a number of cellular functions (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>) [<xref ref-type="bibr" rid="CR1">1</xref>]. Intracellular synthesis is the major source of CoQ<sub>10</sub>, although a small proportion is acquired through diet. The complexity of the biosynthesis (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>) suggests that defects in different biosynthetic enzymes or regulatory proteins may cause different clinical syndromes.
<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Functions of coenzyme Q (modified from [<xref ref-type="bibr" rid="CR1">1</xref>])</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left">Electron carrier in mitochondrial respiratory chain [<xref ref-type="bibr" rid="CR3">3</xref>]</td></tr><tr><td align="left">Extra-mitochondrial electron transport [<xref ref-type="bibr" rid="CR4">4</xref>]</td></tr><tr><td align="left">Antioxidant [<xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td align="left">Regulation of mitochondrial permeability transition pore [<xref ref-type="bibr" rid="CR6">6</xref>]</td></tr><tr><td align="left">Regulation of physiochemical properties of membranes [<xref ref-type="bibr" rid="CR7">7</xref>]</td></tr><tr><td align="left">Modulation of the amount of &#x3B2;-integrins on the surface of blood monocytes [<xref ref-type="bibr" rid="CR8">8</xref>]</td></tr><tr><td align="left">Modulator of endothelial function [<xref ref-type="bibr" rid="CR9">9</xref>]</td></tr><tr><td align="left">Oxidation of sulfide in yeast [<xref ref-type="bibr" rid="CR10">10</xref>]</td></tr><tr><td align="left">Introduction of disulfide bonds in bacteria [<xref ref-type="bibr" rid="CR11">11</xref>]</td></tr></tbody></table></table-wrap><fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>CoQ<sub>10</sub> biosynthetic pathway with eight known biosynthetic enzymes denoted as COQ1-8. CoQ<sub>10</sub> is composed of a benzoquinone and a decaprenyl side chain. While the quinone ring is derived from amino acids tyrosine or phenylalanine, the isoprenoid side chain is produced by addition of isopentenyl pyrophosphate molecules to geranylgeranyl pyrophosphate (derived from mevalonate pathway) by decaprenyl diphosphate synthase. After para-hydroxybenzoate and decaprenyl pyrophosphate are produced, at least seven enzymes (encoded by <italic>COQ2-8</italic>) catalyze condensation, methylation, decarboxylation, and hydroxylation reactions to synthesize CoQ<sub>10</sub></p></caption><graphic position="anchor" xlink:href="11064_2006_9190_Fig1_HTML" id="MO1"/></fig></p>
      <p>Primary CoQ<sub>10</sub> deficiency is an autosomal recessive condition with a clinical spectrum that encompasses at least five major phenotypes: (1) encephalomyopathy characterized by the triad of recurrent myoglobinuria, brain involvement and ragged red fibers; (2) severe infantile multisystemic disease; (3) cerebellar ataxia; (4) Leigh syndrome with growth retardation, ataxia and deafness; and (5) isolated myopathy [<xref ref-type="bibr" rid="CR12">12</xref>&#x2013;<xref ref-type="bibr" rid="CR43">26</xref>].</p>
      <p>Generalized weakness, exercise intolerance, and recurrent myoglobinuria are the distinctive features in the first four patients reported with the encephalomyopathic form, [<xref ref-type="bibr" rid="CR12">12</xref>&#x2013;<xref ref-type="bibr" rid="CR15">15</xref>]; however, myoglobinuria was absent in another patient [<xref ref-type="bibr" rid="CR16">16</xref>]. All the patients described so far have proximal muscle weakness [<xref ref-type="bibr" rid="CR12">12</xref>&#x2013;<xref ref-type="bibr" rid="CR16">16</xref>] The brain involvement is variable; seizures are a common finding [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>], in association with cognitive impairment [<xref ref-type="bibr" rid="CR12">12</xref>] and cerebellar symptoms [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>].</p>
      <p>The second variant, described in three families, manifests as an infantile encephalopathy with renal involvement. R&#xF6;tig and colleagues initially described two siblings with defects of multiple quinone-dependent enzymes ascribed to a deficiency of CoQ<sub>10</sub> in various tissues [<xref ref-type="bibr" rid="CR17">17</xref>]. The patients presented with retinitis pigmentosa, optic nerve atrophy, bilateral sensorineuronal deafness, nephrotic syndrome, progressive ataxia, and cardiomyopathy. In Rahman&#x2019;s patient, hypothermia, lactic acidosis, cerebral and cerebellar atrophy, and developmental delay were associated with renal tubulopathy and ventricular hypertrophy [<xref ref-type="bibr" rid="CR18">18</xref>]. Last year, we described two siblings who presented with nephrotic syndrome due to glomerulosclerosis, and the older sibling developed hypotonia, psychomotor delay, seizures, stroke-like episodes, and cerebellar and cerebral atrophy [<xref ref-type="bibr" rid="CR19">19</xref>]. Interestingly, in these infantile-onset patients, deficiency of CoQ<sub>10</sub> is present not only in skeletal muscle, but also in other tissues and cells including skin fibroblasts. In addition, two adult sisters with encephalopathy, growth retardation, infantilism, ataxia, deafness and lactic acidosis have been described by Van Maldergam [<xref ref-type="bibr" rid="CR23">23</xref>].</p>
      <p>Cerebellar ataxia is the most common phenotype associated with CoQ<sub>10</sub> deficiency with 21 reported patients [<xref ref-type="bibr" rid="CR20">20</xref>&#x2013;<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR43">26</xref>]. Cerebellar ataxia and cerebellar atrophy are present in all the patients. Epilepsy is the most common associated feature, but pyramidal signs, mental retardation, myopathic weakness, and delayed motor milestones are other variably associated symptoms and signs. Except for two adult brothers with cerebellar ataxia and hypogonadism [<xref ref-type="bibr" rid="CR22">22</xref>], the condition begins in childhood or adolescence. Muscle morphology does not show ragged-red fibers and lipid storage myopathy and CoQ<sub>10</sub> is moderately reduced in skin fibroblasts.</p>
      <p>The clinical presentation of the variant isolated myopathy, recently described in four patients, is subacute onset of exercise intolerance and proximal limb weakness at variable ages. All patients have lipid storage and ragged-red fibers in muscle, as well as increased serum lactate and creatine kinase (CK) [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. In all the patients with different phenotypes, respiratory chain enzymes analyses show reduced activities of complex I&#xA0;+&#xA0;III and II&#xA0;+&#xA0;III with normal activities of isolated complex I and III.</p>
      <p>In most of the reported patients, the exact site and nature of the defects in the biosynthesis of CoQ<sub>10</sub> have not yet been identified. Because ubiquinone biosynthesis is complex and not fully defined (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>), identification of the molecular genetic defect is not straightforward.</p>
      <p>Undetectable CoQ<sub>10</sub> and low levels of decaprenylpyrophosphate, an intermediate compound in the synthesis of the lateral chain of CoQ<sub>10</sub> were found in the fibroblasts of the patient reported by R&#xF6;tig and colleagues suggesting a defect in the synthesis of the decaprenyl side-chain, but they did not find any mutation in the cDNA of <italic>COQ1</italic>, the gene encoding transprenyltransferase, the enzyme that synthesizes decaprenylpyrophosphate [<xref ref-type="bibr" rid="CR17">17</xref>].</p>
      <p>This year, in two siblings with the infantile form of CoQ<sub>10</sub> deficiency, we reported a homozygous missense mutation (Y297C) in the <italic>COQ2</italic> gene, which encodes para-hydroxybenzoate (PHB) polyprenyl transferase. PHB-polyprenyl transferase mediates the conjugation of the benzoquinone ring with the decaprenyl side chain. Biochemical assays measuring incorporation of radiolabeled PHB or decaprenyl-PP into CoQ<sub>10</sub> in skin fibroblasts from the proband showed 23&#x2013;25% of control fibroblasts activity [<xref ref-type="bibr" rid="CR26">27</xref>] confirming the defect of CoQ<sub>10</sub> biosynthesis.</p>
      <p>The finding of a homozygous stop codon mutation in the <italic>APTX</italic> gene which is known to cause ataxia-oculomotor-aprataxia 1 (AOA1), in three siblings with cerebellar ataxia and CoQ<sub>10</sub> deficiency, supports the hypothesis that the ataxic form is a genetically heterogeneous disease in which CoQ<sub>10</sub> deficiency can be secondary [<xref ref-type="bibr" rid="CR27">28</xref>]. Aprataxin is a member of the histidine triad superfamily and may be involved in nuclear DNA single strand break repair [<xref ref-type="bibr" rid="CR28">29</xref>&#x2013;<xref ref-type="bibr" rid="CR30">31</xref>]. Despite the lack of an obvious link between aprataxin and regulation of CoQ<sub>10</sub> synthesis or catabolism, our findings, coupled with the clinical improvement of patients after CoQ<sub>10</sub> supplementation, suggest that CoQ<sub>10</sub> deficiency plays a pathogenic role in AOA1. Intriguingly, both CoQ<sub>10</sub> and cholesterol share a common biosynthetic pathway, therefore, in AOA1, altered levels of these molecules could be due to aberrant biosynthesis.</p>
      <p>Patients with all forms of CoQ<sub>10</sub> deficiency have shown clinical improvement with oral CoQ<sub>10</sub> supplementation. The beneficial effects of exogenous CoQ<sub>10</sub> require high doses and long-term administration [<xref ref-type="bibr" rid="CR31">32</xref>, <xref ref-type="bibr" rid="CR32">33</xref>]; its oral bioavailability is poor due to its extreme hydrophobicity; therefore, only a small fraction of orally administered CoQ<sub>10</sub> reaches the circulatory system, and augmentation of mitochondrial CoQ<sub>10</sub> content is even less effective. Beneficial effects of CoQ<sub>10</sub> supplementation are supported by in vitro correction of biochemical and histological abnormalities [<xref ref-type="bibr" rid="CR12">12</xref>&#x2013;<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. However, while muscle abnormalities improve clinically and biochemically, in general, cerebral symptoms are only partially ameliorated [<xref ref-type="bibr" rid="CR16">16</xref>]. This difference could be explained by the presence of irreversible structural brain damage before treatment or the poor penetration of CoQ<sub>10</sub> across the blood-brain barrier. Increases in plasma concentrations of CoQ<sub>10</sub> after oral supplementation in both humans and animals has been well-documented, but early work questioned whether CoQ<sub>10</sub> accumulates in tissues [<xref ref-type="bibr" rid="CR33">34</xref>] and studies of 45-day-old rodents showed little or no change in rodent brain CoQ<sub>10</sub> concentrations after oral administration perhaps because levels of CoQ<sub>10</sub> are tightly regulated in young animals or may be saturated in membranes [<xref ref-type="bibr" rid="CR33">34</xref>, <xref ref-type="bibr" rid="CR34">35</xref>]. In contrast, administration of very high doses of CoQ<sub>10</sub> (200&#xA0;mg/kg daily) to 12&#x2013;24&#xA0;month-old rats produced significant increases in brain CoQ<sub>10</sub> levels [<xref ref-type="bibr" rid="CR35">36</xref>], but a more recent study of the regional distribution of CoQ in 16&#xA0;week-old rat brain before and after 4&#xA0;weeks of moderately high exogenous dietary CoQ<sub>10</sub> (20&#xA0;mg/kg daily) supplementation showed that the concentration of CoQ was essentially unchanged in the cortex and in the striatum [<xref ref-type="bibr" rid="CR36">37</xref>]. That study also demonstrated that the cerebellum, of the 7 brain regions dissected, contains the lowest levels of CoQ. If human brain has the same regional distribution of CoQ<sub>10</sub> as rat brain, the cerebellum may have the narrowest safety margin and therefore would be the first tissue to suffer from a pathological shortage of CoQ<sub>10</sub>. Moreover, to function as an antioxidant, CoQ<sub>10</sub> must be in the reduced form but normally only 20% of the lipid is reduced in the brain. The high proportion of oxidized CoQ<sub>10</sub> in the brain could be a reflection of the high oxygen consumption in this tissue, causing an increased demand of anti-oxidants [<xref ref-type="bibr" rid="CR37">38</xref>]. Therefore, CoQ<sub>10</sub> deficiency could be another form of inherited ataxia due to oxidative damage, as vitamin E deficiency.</p>
      <p>Oxidative damage and mitochondrial dysfunction have also been implicated in neurodegenerative diseases such Parkinson disease (PD), Alzheimer disease (AD), and Friedreich&#x2019;s ataxia (FRDA) [<xref ref-type="bibr" rid="CR38">39</xref>&#x2013;<xref ref-type="bibr" rid="CR40">41</xref>]. Preclinical studies have indicated that CoQ<sub>10</sub> can protect the nigrostriatal dopaminergic system and high doses (1200&#xA0;mg daily) of CoQ<sub>10</sub> for 16&#xA0;months appeared to slow progression PD [<xref ref-type="bibr" rid="CR39">40</xref>, <xref ref-type="bibr" rid="CR41">42</xref>]. In 10 FRDA patients treated for 47&#xA0;months high doses of CoQ<sub>10</sub> (400&#xA0;mg daily) with vitamin E (2100&#xA0;IU daily), improved bioenergetics in heart and skeletal muscle, improved cardiac function by echocardiography, and, possibly less clinical decline compared to historical controls [<xref ref-type="bibr" rid="CR42">43</xref>]. Larger studies are necessary to better define the short- and long-term effects of CoQ10 as primary or adjunctive therapy in neurodegenerative diseases.</p>
      <p>Deficiency of CoQ<sub>10 </sub>has been associated with a variety of neurological disorders that respond to oral supplementation. We have demonstrated that CoQ<sub>10</sub> deficiency can be primary due to a defect of biosynthesis or secondary as in patients with <italic>APTX</italic> mutations. The response of both groups of patients to oral supplementation suggests that exogenous CoQ<sub>10</sub> is taken up by affected tissues and can correct biochemical derangements. Further studies to define CoQ<sub>10</sub> deficiency syndrome will reveal new causes, enhance our understanding of its pathogenesis, and may provide novel insights that may be relevant to other neurodegenerative diseases.</p>
    </sec>
  </body>
  <back>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turunen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Olsson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dallner</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Metabolism and function of coenzyme Q</article-title>
          <source>Biochim Biophys Acta</source>
          <year>2004</year>
          <volume>1660</volume>
          <fpage>171</fpage>
          <lpage>199</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbamem.2003.11.012</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Turunen M, Olsson J, Dallner G (2004) Metabolism and function of coenzyme Q. Biochim Biophys Acta 1660:171&#x2013;199 <pub-id pub-id-type="pmid">14757233</pub-id></citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crane</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Hatefi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Lester</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Widmer</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Isolation of a quinone from beef heart mitochondria</article-title>
          <source>Biochim Biophys Acta</source>
          <year>1957</year>
          <volume>25</volume>
          <fpage>220</fpage>
          <lpage>221</lpage>
          <pub-id pub-id-type="doi">10.1016/0006-3002(57)90457-2</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Crane FL, Hatefi Y, Lester RL, Widmer C (1957) Isolation of a quinone from beef heart mitochondria. Biochim Biophys Acta 25:220&#x2013;221 <pub-id pub-id-type="pmid">13445756</pub-id></citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Santos-Ocana</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Do</surname>
              <given-names>TQ</given-names>
            </name>
            <name>
              <surname>Padilla</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Navas</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>CF</given-names>
            </name>
          </person-group>
          <article-title>Uptake of exogenous coenzyme Q and transport to mitochondria is required for <italic>bc</italic>1 complex stability in yeast coq mutants</article-title>
          <source>J Biol Chem</source>
          <year>2002</year>
          <volume>277</volume>
          <fpage>10973</fpage>
          <lpage>10981</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M112222200</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Santos-Ocana C, Do TQ, Padilla S, Navas P, Clarke CF (2002) Uptake of exogenous coenzyme Q and transport to mitochondria is required for bc1 complex stability in yeast coq mutants. J Biol Chem 277:10973&#x2013;10981 <pub-id pub-id-type="pmid">11788608</pub-id></citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sun</surname>
              <given-names>IL</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Crane</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Morre</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Lindgren</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Low</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Requirement for coenzyme Q in plasma membrane electron transport</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1992</year>
          <volume>89</volume>
          <fpage>11126</fpage>
          <lpage>11130</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.89.23.11126</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Sun IL, Sun EE, Crane FL, Morre DJ, Lindgren A, Low H (1992) Requirement for coenzyme Q in plasma membrane electron transport. Proc Natl Acad Sci USA 89:11126&#x2013;11130 <pub-id pub-id-type="pmid">1454789</pub-id></citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Villalba</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Navas</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Plasma membrane redox system in the control of stress-induced apoptosis</article-title>
          <source>Antioxid Redox Signal</source>
          <year>2000</year>
          <volume>2</volume>
          <fpage>213</fpage>
          <lpage>230</lpage>
        </citation>
        <citation citation-type="display-unstructured">Villalba JM, Navas P (2000) Plasma membrane redox system in the control of stress-induced apoptosis. Antioxid Redox Signal 2:213&#x2013;230 <pub-id pub-id-type="pmid">11229527</pub-id></citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walter</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Miyoshi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Leverve</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Bernardi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Fontaine</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Regulation of the mitochondrial permeability transition pore by ubiquinone analogs. A progress report</article-title>
          <source>Free Radic Res</source>
          <year>2002</year>
          <volume>36</volume>
          <fpage>405</fpage>
          <lpage>412</lpage>
          <pub-id pub-id-type="doi">10.1080/10715760290021252</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Walter L, Miyoshi H, Leverve X, Bernardi P, Fontaine E (2002) Regulation of the mitochondrial permeability transition pore by ubiquinone analogs. A progress report. Free Radic Res 36:405&#x2013;412 <pub-id pub-id-type="pmid">12069104</pub-id></citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cornell</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Keniry</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Post</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Robertson</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Weir</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Westerman</surname>
              <given-names>PW</given-names>
            </name>
          </person-group>
          <article-title>Location and activity of ubiquinone 10 and ubiquinone analogues in model and biological membranes</article-title>
          <source>Biochemistry</source>
          <year>1987</year>
          <volume>26</volume>
          <fpage>7702</fpage>
          <lpage>7707</lpage>
          <pub-id pub-id-type="doi">10.1021/bi00398a025</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Cornell BA, Keniry MA, Post A, Robertson RN, Weir LE, Westerman PW (1987) Location and activity of ubiquinone 10 and ubiquinone analogues in model and biological membranes. Biochemistry 26:7702&#x2013;7707 <pub-id pub-id-type="pmid">3322405</pub-id></citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turunen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wehlin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sjoberg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lundahl</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dallner</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Brismar</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sindelar</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Beta2-Integrin and lipid modifications indicate a non-antioxidant mechanism for the anti-atherogenic effect of dietary coenzyme Q10</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2002</year>
          <volume>296</volume>
          <fpage>255</fpage>
          <lpage>260</lpage>
          <pub-id pub-id-type="doi">10.1016/S0006-291X(02)00871-9</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Turunen M, Wehlin L, Sjoberg M, Lundahl J, Dallner G, Brismar K, Sindelar PJ (2002) Beta2-Integrin and lipid modifications indicate a non-antioxidant mechanism for the anti-atherogenic effect of dietary coenzyme Q10. Biochem Biophys Res Commun 296:255&#x2013;260 <pub-id pub-id-type="pmid">12163010</pub-id></citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Watts</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Playford</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Croft</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Ward</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Burke</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus</article-title>
          <source>Diabetologia</source>
          <year>2002</year>
          <volume>45</volume>
          <fpage>420</fpage>
          <lpage>426</lpage>
          <pub-id pub-id-type="doi">10.1007/s00125-001-0760-y</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Watts GF, Playford DA, Croft KD, Ward NC, Mori TA, Burke V (2002) Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus. Diabetologia 45:420&#x2013;426 <pub-id pub-id-type="pmid">11914748</pub-id></citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saiki</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ogiyama</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kainou</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nishi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Matsuda</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kawamukai</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Pleiotropic phenotypes of fission yeast defective in ubiquinone-10 production. A study from the abc1Sp (coq8Sp) mutant</article-title>
          <source>Biofactors</source>
          <year>2003</year>
          <volume>18</volume>
          <fpage>229</fpage>
          <lpage>235</lpage>
        </citation>
        <citation citation-type="display-unstructured">Saiki R, Ogiyama Y, Kainou T, Nishi T, Matsuda H, Kawamukai M (2003) Pleiotropic phenotypes of fission yeast defective in ubiquinone-10 production. A study from the abc1Sp (coq8Sp) mutant. Biofactors 18:229&#x2013;235 <pub-id pub-id-type="pmid">14695938</pub-id></citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bader</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Xie</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Bardwell</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Disulfide bonds are generated by quinone reduction</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>26082</fpage>
          <lpage>26088</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M003850200</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Bader MW, Xie T, Yu CA, Bardwell JC (2000) Disulfide bonds are generated by quinone reduction. J Biol Chem 275:26082&#x2013;26088 <pub-id pub-id-type="pmid">10854438</pub-id></citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ogasahara</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Engel</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Frens</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Mack</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1989</year>
          <volume>86</volume>
          <fpage>2379</fpage>
          <lpage>2382</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.86.7.2379</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Ogasahara S, Engel AG, Frens D, Mack D (1989) Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci USA 86:2379&#x2013;2382 <pub-id pub-id-type="pmid">2928337</pub-id></citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sobreira</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hirano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shanske</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Keller</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Haller</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mitochondrial encephalomyopathy with coenzyme Q10 deficiency</article-title>
          <source>Neurology</source>
          <year>1997</year>
          <volume>48</volume>
          <fpage>1238</fpage>
          <lpage>1243</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sobreira C, Hirano M, Shanske S, Keller RK, Haller RG, Davidson E, et al. (1997) Mitochondrial encephalomyopathy with coenzyme Q10 deficiency. Neurology 48:1238&#x2013;1243 <pub-id pub-id-type="pmid">9153450</pub-id></citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Di Giovanni</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mirabella</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Spinazzola</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Crociani</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Silvestri</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Broccolini</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency</article-title>
          <source>Neurology</source>
          <year>2001</year>
          <volume>57</volume>
          <fpage>515</fpage>
          <lpage>518</lpage>
        </citation>
        <citation citation-type="display-unstructured">Di Giovanni S, Mirabella M, Spinazzola A, Crociani P, Silvestri G, Broccolini A, et al. (2001) Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency. Neurology 57:515&#x2013;518 <pub-id pub-id-type="pmid">11502923</pub-id></citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boitier</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Degoul</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Desguerre</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Charpentier</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Francois</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ponsot</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A case of mitochondrial encephalomyopathy associated with a muscle coenzyme Q10 deficiency</article-title>
          <source>J Neurol Sci</source>
          <year>1998</year>
          <volume>156</volume>
          <fpage>41</fpage>
          <lpage>46</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-510X(98)00006-9</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Boitier E, Degoul F, Desguerre I, Charpentier C, Francois D, Ponsot G, et al. (1998) A case of mitochondrial encephalomyopathy associated with a muscle coenzyme Q10 deficiency. J Neurol Sci 156:41&#x2013;46 <pub-id pub-id-type="pmid">9559985</pub-id></citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aure</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Benoist</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Ogier Baulny</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Romero</surname>
              <given-names>NB</given-names>
            </name>
            <name>
              <surname>Rigal</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Lombes</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Progression despite replacement of a myopathic form of coenzyme Q10 defect</article-title>
          <source>Neurology</source>
          <year>2004</year>
          <volume>63</volume>
          <fpage>727</fpage>
          <lpage>729</lpage>
        </citation>
        <citation citation-type="display-unstructured">Aure K, Benoist JF, de Ogier Baulny H, Romero NB, Rigal O, Lombes A (2004) Progression despite replacement of a myopathic form of coenzyme Q10 defect. Neurology 63:727&#x2013;729 <pub-id pub-id-type="pmid">15326254</pub-id></citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rotig</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Appelkvist</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Geromel</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Chretien</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kadhom</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Edery</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency</article-title>
          <source>Lancet</source>
          <year>2000</year>
          <volume>356</volume>
          <fpage>391</fpage>
          <lpage>395</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(00)02531-9</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Rotig A, Appelkvist EL, Geromel V, Chretien D, Kadhom N, Edery P et al. (2000) Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 356:391&#x2013;395 <pub-id pub-id-type="pmid">10972372</pub-id></citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rahman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hargreaves</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Clayton</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Heales</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Neonatal presentation of coenzyme Q10 deficiency</article-title>
          <source>J Pediatr</source>
          <year>2001</year>
          <volume>139</volume>
          <fpage>456</fpage>
          <lpage>458</lpage>
          <pub-id pub-id-type="doi">10.1067/mpd.2001.117575</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Rahman S, Hargreaves I, Clayton P, Heales S (2001) Neonatal presentation of coenzyme Q10 deficiency. J Pediatr 139:456&#x2013;458 <pub-id pub-id-type="pmid">11562630</pub-id></citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Salviati</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sacconi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Murer</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Zacchello</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Franceschini</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Laverda</surname>
              <given-names>AM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition</article-title>
          <source>Neurology</source>
          <year>2005</year>
          <volume>65</volume>
          <fpage>606</fpage>
          <lpage>608</lpage>
          <pub-id pub-id-type="doi">10.1212/01.wnl.0000172859.55579.a7</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Salviati L, Sacconi S, Murer L, Zacchello G, Franceschini L, Laverda AM et al. (2005) Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition. Neurology 65:606&#x2013;608 <pub-id pub-id-type="pmid">16116126</pub-id></citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Musumeci</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Naini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Slonim</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Skavin</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Hadjigeorgiou</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Krawiecki</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Familial cerebellar ataxia with muscle coenzyme Q10 deficiency</article-title>
          <source>Neurology</source>
          <year>2001</year>
          <volume>56</volume>
          <fpage>849</fpage>
          <lpage>855</lpage>
        </citation>
        <citation citation-type="display-unstructured">Musumeci O, Naini A, Slonim AE, Skavin N, Hadjigeorgiou GL, Krawiecki N et al. (2001) Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology 56:849&#x2013;855 <pub-id pub-id-type="pmid">11294920</pub-id></citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lamperti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Naini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hirano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vivo</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Bertini</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Servidei</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cerebellar ataxia and coenzyme Q10 deficiency</article-title>
          <source>Neurology</source>
          <year>2003</year>
          <volume>60</volume>
          <fpage>1206</fpage>
          <lpage>1208</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lamperti C, Naini A, Hirano M, De Vivo DC, Bertini E, Servidei S et al (2003) Cerebellar ataxia and coenzyme Q10 deficiency. Neurology 60:1206&#x2013;1208 <pub-id pub-id-type="pmid">12682339</pub-id></citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gironi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lamperti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Nemni</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Moggio</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Comi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Guerini</surname>
              <given-names>FR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency</article-title>
          <source>Neurology</source>
          <year>2004</year>
          <volume>62</volume>
          <fpage>818</fpage>
          <lpage>820</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gironi M, Lamperti C, Nemni R, Moggio M, Comi G, Guerini FR et al. (2004) Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency. Neurology 62:818&#x2013;820 <pub-id pub-id-type="pmid">15007142</pub-id></citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maldergem</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Trijbels</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>DiMauro</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sindelar</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Musumeci</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Janssen</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Coenzyme Q-responsive Leigh&#x2019;s encephalopathy in two sisters</article-title>
          <source>Ann Neurol</source>
          <year>2002</year>
          <volume>52</volume>
          <fpage>750</fpage>
          <lpage>754</lpage>
          <pub-id pub-id-type="doi">10.1002/ana.10371</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Van Maldergem L, Trijbels F, DiMauro S, Sindelar PJ, Musumeci O, Janssen A et al. (2002) Coenzyme Q-responsive Leigh&#x2019;s encephalopathy in two sisters. Ann Neurol 52:750&#x2013;754 <pub-id pub-id-type="pmid">12447928</pub-id></citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lalani</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Vladutiu</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Plunkett</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lotze</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Adesina</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Scaglia</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency</article-title>
          <source>Arch Neurol</source>
          <year>2005</year>
          <volume>62</volume>
          <fpage>317</fpage>
          <lpage>320</lpage>
          <pub-id pub-id-type="doi">10.1001/archneur.62.2.317</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Lalani SR, Vladutiu GD, Plunkett K, Lotze TE, Adesina AM, Scaglia F (2005) Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency. Arch Neurol 62:317&#x2013;320 <pub-id pub-id-type="pmid">15710863</pub-id></citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horvath</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Schneiderat</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Schoser</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Gempel</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Neuen-Jacob</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ploger</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Coenzyme Q10 deficiency and isolated myopathy</article-title>
          <source>Neurology</source>
          <year>2006</year>
          <volume>66</volume>
          <fpage>253</fpage>
          <lpage>255</lpage>
          <pub-id pub-id-type="doi">10.1212/01.wnl.0000194241.35115.7c</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Horvath R, Schneiderat P, Schoser BG, Gempel K, Neuen-Jacob E, Ploger H et al. (2006) Coenzyme Q10 deficiency and isolated myopathy. Neurology 66:253&#x2013;255 <pub-id pub-id-type="pmid">16434667</pub-id></citation>
      </ref>
      <ref id="CR43">
        <label>26.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Artuch</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Brea-Calvo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Briones</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Aracil</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Galv&#xE1;n</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Espin&#xF3;s</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cerebellar ataxia with coenzyme Q10 deficiency: Diagnosis and followup after coenzyme Q10 supplementation</article-title>
          <source>J Neurol Sci</source>
          <year>2006</year>
          <volume>246</volume>
          <fpage>153</fpage>
          <lpage>158</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jns.2006.01.021</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Artuch R, Brea-Calvo G, Briones P, Aracil A, Galv&#xE1;n M, Espin&#xF3;s C et al. (2006) Cerebellar ataxia with coenzyme Q10 deficiency: Diagnosis and followup after coenzyme Q10 supplementation. J Neurol Sci 246:153&#x2013;158 <pub-id pub-id-type="pmid">16677673</pub-id></citation>
      </ref>
      <ref id="CR26">
        <label>27.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quinzii</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Naini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Salviati</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Trevisson</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Navas</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Dimauro</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A Mutation in Para-Hydroxybenzoate-Polyprenyl Transferase (COQ2) Causes Primary Coenzyme Q10 Deficiency</article-title>
          <source>Am J Hum Genet</source>
          <year>2006</year>
          <volume>78</volume>
          <fpage>345</fpage>
          <lpage>349</lpage>
          <pub-id pub-id-type="doi">10.1086/500092</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Quinzii C, Naini A, Salviati L, Trevisson E, Navas P, Dimauro S et al. (2006) A Mutation in Para-Hydroxybenzoate-Polyprenyl Transferase (COQ2) Causes Primary Coenzyme Q10 Deficiency. Am J Hum Genet 78:345&#x2013;349 <pub-id pub-id-type="pmid">16400613</pub-id></citation>
      </ref>
      <ref id="CR27">
        <label>28.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quinzii</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Kattah</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Naini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Akman</surname>
              <given-names>HO</given-names>
            </name>
            <name>
              <surname>Mootha</surname>
              <given-names>VK</given-names>
            </name>
            <name>
              <surname>DiMauro</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation</article-title>
          <source>Neurology</source>
          <year>2005</year>
          <volume>64</volume>
          <fpage>539</fpage>
          <lpage>541</lpage>
        </citation>
        <citation citation-type="display-unstructured">Quinzii CM, Kattah AG, Naini A, Akman HO, Mootha VK, DiMauro S et al. (2005) Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology 64:539&#x2013;541 <pub-id pub-id-type="pmid">15699391</pub-id></citation>
      </ref>
      <ref id="CR28">
        <label>29.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Date</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Onodera</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Iwabuchi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Uekawa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Igarashi</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene</article-title>
          <source>Nat Genet</source>
          <year>2001</year>
          <volume>29</volume>
          <fpage>184</fpage>
          <lpage>188</lpage>
          <pub-id pub-id-type="doi">10.1038/ng1001-184</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Date H, Onodera O, Tanaka H, Iwabuchi K, Uekawa K, Igarashi S et al. (2001) Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene. Nat Genet 29:184&#x2013;188 <pub-id pub-id-type="pmid">11586299</pub-id></citation>
      </ref>
      <ref id="CR29">
        <label>30.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moreira</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Barbot</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tachi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kozuka</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Uchida</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Gibson</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin</article-title>
          <source>Nat Genet</source>
          <year>2001</year>
          <volume>29</volume>
          <fpage>189</fpage>
          <lpage>193</lpage>
          <pub-id pub-id-type="doi">10.1038/ng1001-189</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Moreira MC, Barbot C, Tachi N, Kozuka N, Uchida E, Gibson T et al. (2001) The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Nat Genet 29:189&#x2013;193 <pub-id pub-id-type="pmid">11586300</pub-id></citation>
      </ref>
      <ref id="CR30">
        <label>31.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ahel Rass</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>El-Khamisy</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Katyal</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Clements</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>McKinnon</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Caldecott</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates</article-title>
          <source>Nature</source>
          <year>2006</year>
          <volume>443</volume>
          <fpage>713</fpage>
          <lpage>716</lpage>
          <pub-id pub-id-type="doi">10.1038/nature05164</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Ahel Rass U, El-Khamisy SF, Katyal S, Clements PM, McKinnon PJ, Caldecott KW, West SC (2006) The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates. Nature 443:713&#x2013;716 <pub-id pub-id-type="pmid">16964241</pub-id></citation>
      </ref>
      <ref id="CR31">
        <label>32.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>James</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Cocheme</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools</article-title>
          <source>J Biol Chem</source>
          <year>2005</year>
          <volume>280</volume>
          <fpage>21295</fpage>
          <lpage>21312</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M501527200</pub-id>
        </citation>
        <citation citation-type="display-unstructured">James AM, Cocheme HM, Smith RA, Murphy MP (2005) Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools. J Biol Chem 280:21295&#x2013;21312 <pub-id pub-id-type="pmid">15788391</pub-id></citation>
      </ref>
      <ref id="CR32">
        <label>33.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bhagavan</surname>
              <given-names>HN</given-names>
            </name>
            <name>
              <surname>Chopra</surname>
              <given-names>RK</given-names>
            </name>
          </person-group>
          <article-title>Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics</article-title>
          <source>Free Radic Res</source>
          <year>2006</year>
          <volume>40</volume>
          <fpage>445</fpage>
          <lpage>453</lpage>
          <pub-id pub-id-type="doi">10.1080/10715760600617843</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Bhagavan HN, Chopra RK (2006) Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 40:445&#x2013;453 <pub-id pub-id-type="pmid">16551570</pub-id></citation>
      </ref>
      <ref id="CR33">
        <label>34.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Aberg</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Appelkvist</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Dallner</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ernster</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Uptake of dietary coenzyme Q supplement is limited in rats</article-title>
          <source>J Nutr</source>
          <year>1995</year>
          <volume>125</volume>
          <fpage>446</fpage>
          <lpage>453</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zhang Y, Aberg F, Appelkvist EL, Dallner G, Ernster L (1995) Uptake of dietary coenzyme Q supplement is limited in rats. J Nutr 125:446&#x2013;453 <pub-id pub-id-type="pmid">7876919</pub-id></citation>
      </ref>
      <ref id="CR34">
        <label>35.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bentinger</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dallner</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Chojnacki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Swiezewska</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Distribution and breakdown of labeled coenzyme Q10 in rat</article-title>
          <source>Free Radic Biol Med</source>
          <year>2003</year>
          <volume>34</volume>
          <fpage>563</fpage>
          <lpage>575</lpage>
          <pub-id pub-id-type="doi">10.1016/S0891-5849(02)01357-6</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Bentinger M, Dallner G, Chojnacki T, Swiezewska E (2003) Distribution and breakdown of labeled coenzyme Q10 in rat. Free Radic Biol Med 34:563&#x2013;575 <pub-id pub-id-type="pmid">12614845</pub-id></citation>
      </ref>
      <ref id="CR35">
        <label>36.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matthews</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Browne</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Baik</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Beal</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1998</year>
          <volume>95</volume>
          <fpage>8892</fpage>
          <lpage>8897</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.95.15.8892</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Matthews RT, Yang L, Browne S, Baik M, Beal MF (1998) Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci USA 95:8892&#x2013;8897 <pub-id pub-id-type="pmid">9671775</pub-id></citation>
      </ref>
      <ref id="CR36">
        <label>37.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Naini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lewis</surname>
              <given-names>VJ</given-names>
            </name>
            <name>
              <surname>Hirano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>DiMauro</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Primary coenzyme Q10 deficiency and the brain</article-title>
          <source>Biofactors</source>
          <year>2003</year>
          <volume>18</volume>
          <fpage>145</fpage>
          <lpage>152</lpage>
        </citation>
        <citation citation-type="display-unstructured">Naini A, Lewis VJ, Hirano M, DiMauro S (2003) Primary coenzyme Q10 deficiency and the brain. Biofactors 18:145&#x2013;152 <pub-id pub-id-type="pmid">14695930</pub-id></citation>
      </ref>
      <ref id="CR37">
        <label>38.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turunen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Swiezewska</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Chojnacki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sindelar</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Dallner</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Regulatory aspects of coenzyme Q metabolism</article-title>
          <source>Free Radic Res</source>
          <year>2002</year>
          <volume>36</volume>
          <fpage>437</fpage>
          <lpage>443</lpage>
          <pub-id pub-id-type="doi">10.1080/10715760290021298</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Turunen M, Swiezewska E, Chojnacki T, Sindelar P, Dallner G (2002) Regulatory aspects of coenzyme Q metabolism. Free Radic Res 36:437&#x2013;443 <pub-id pub-id-type="pmid">12069108</pub-id></citation>
      </ref>
      <ref id="CR38">
        <label>39.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beal</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial dysfunction and oxidative damage in Alzheimer&#x2019;s and Parkinson&#x2019;s diseases and coenzyme Q10 as a potential treatment</article-title>
          <source>J Bioenerg Biomembr</source>
          <year>2004</year>
          <volume>36</volume>
          <fpage>381</fpage>
          <lpage>386</lpage>
          <pub-id pub-id-type="doi">10.1023/B:JOBB.0000041772.74810.92</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Beal MF (2004) Mitochondrial dysfunction and oxidative damage in Alzheimer&#x2019;s and Parkinson&#x2019;s diseases and coenzyme Q10 as a potential treatment. J Bioenerg Biomembr 36:381&#x2013;386 <pub-id pub-id-type="pmid">15377876</pub-id></citation>
      </ref>
      <ref id="CR39">
        <label>40.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shults</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Haas</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Clinical trials of coenzyme Q10 in neurological disorders</article-title>
          <source>Biofactors</source>
          <year>2005</year>
          <volume>25</volume>
          <fpage>117</fpage>
          <lpage>126</lpage>
        </citation>
        <citation citation-type="display-unstructured">Shults CW, Haas R (2005) Clinical trials of coenzyme Q10 in neurological disorders. Biofactors 25:117&#x2013;126 <pub-id pub-id-type="pmid">16873936</pub-id></citation>
      </ref>
      <ref id="CR40">
        <label>41.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schapira</surname>
              <given-names>AH</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial diseases</article-title>
          <source>Lancet 1</source>
          <year>2006</year>
          <volume>368</volume>
          <fpage>70</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(06)68970-8</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Schapira AH (2006) Mitochondrial diseases. Lancet 1 368:70&#x2013;82 </citation>
      </ref>
      <ref id="CR41">
        <label>42.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shults</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Oakes</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kieburtz</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Beal</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Haas</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Plumb</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline</article-title>
          <source>Arch Neurol</source>
          <year>2002</year>
          <volume>59</volume>
          <fpage>1541</fpage>
          <lpage>1550</lpage>
          <pub-id pub-id-type="doi">10.1001/archneur.59.10.1541</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Shults C, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S et al. (2002) Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol 59:1541&#x2013;1550 <pub-id pub-id-type="pmid">12374491</pub-id></citation>
      </ref>
      <ref id="CR42">
        <label>43.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hart</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lodi</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rajagopalan</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bradley</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Crilley</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up</article-title>
          <source>Arch Neurol</source>
          <year>2005</year>
          <volume>62</volume>
          <fpage>621</fpage>
          <lpage>626</lpage>
          <pub-id pub-id-type="doi">10.1001/archneur.62.4.621</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Hart P, Lodi R, Rajagopalan B, Bradley JL, Crilley JG, Turner C et al. (2005) Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up. Arch Neurol 62:621&#x2013;626 <pub-id pub-id-type="pmid">15824263</pub-id></citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn>
        <p>Special issue dedicated to John P. Blass.</p>
      </fn>
    </fn-group>
  </back>
</article>
</pmc-articleset>